Baseline T1 | 3 months T2 | 6 months T3 | Test-statistic | |
---|---|---|---|---|
Number of participants with UI | ||||
Intervention group | 29/51 | 25/51 | 18/51 | Zā=āā.053ā” |
Control group | 36/60 | 31/60 | 26/60 | Zā=āā.531Ā§ |
Frequency incontinence episodes (Number/ 3 days); mean (sd) | ||||
Intervention group (nā=ā51) | 9.0 (12.2) | 6.6 (9.6) | 4.4 (7.4) | Fā=ā0.1 |
Control group (nā=ā60) | 9.3 (11.3) | 7.1 (10.5) | 5.4 (8.5) | |
Physical Performance Test (0-28ā ); mean (sd) | ||||
Intervention group (nā=ā51) | 16.7 (4.7) | - | 18.8 (3.9) | Fā=ā10.1* |
Control group (nā=ā60) | 16.4 (4.5) | - | 15.7 (4.5) | |
Health Related Quality of Life SF-12 (mental; 0-100ā ); mean (sd) | ||||
Intervention group (nā=ā51) | 51.4 (10.5) | - | 49.9 (10.9) | Fā=ā1.5 |
Control group (nā=ā60) | 52.7 (10.1) | - | 53.6 (7.7) | |
Health Related Quality of Life SF-12 (physical; 0-100ā ); mean (sd) | ||||
Intervention group (nā=ā51) | 35.5 (11.0) | - | 36.6 (11.2) | Fā=ā2.4 |
Control group (nā=ā60) | 34.7 (10.2) | - | 32.4 (11.2) | |
Specific Quality of Life (I-QOL; 0-110ā ); mean (sd) | ||||
Intervention group (nā=ā51) | 66.6 (15.0) | - | 63.5 (15.0) | Fā=ā0.5ā„ |
Control group (nā=ā60) | 59.1 (15.2) | - | 66.1 (13.2) |